Our History

Medicure was founded in 1997 and became a public company in November 1999. As a U.S focused Specialty Pharma company with established sales of Aggrastat, Medicure carefully monitors opportunities within its own pipeline of products and possible strategic acquisitions in order to realize long-term value.